Note: Ingredients listed on restricted chemical lists
EC/CAS
265-148-2/64742-46-7
Name of the chemical
Distillates (petroleum), hydrotreated middle
Concentration
75-<90 1-<5
EC/CAS
273-066-3/68937-41-7
Name of the chemical
Isopropylphenyl phosphate
Concentration
0.5-<1 <0.25
EC/CAS
204-881-4/128-37-0
Name of the chemical
2,6-di-tert-butyl-p-cresol
Concentration
<0.25
General Information
Revision date
2012-11-16
Product name
Energol SHF-LT 15
supplier name
Telko Oy
Icons in SDS
Company Information
company name
Telko Oy
e-mail address of the competent person responsible for the Safety Data Sheet
MSDSadvice@bp.com
Section 2
Product definition
Mixture
EU Classification
Directive 1999/45/EC [DPD] The product is classified as dangerous according to Directive 1999/45/EC and its amendments.
Classifications
Xn; R20 Xi; R38 N; R51/53
Health hazards
Harmful by inhalation. Irritating to skin.
Environmental hazards
Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. See Section 16 for the full text of the R phrases or H statements declared above. See sections 11 and 12 for more detailed information on health effects and symptoms and environmental hazards.
Hazard statements
Harmful Dangerous for the R20- Harmful by inhalation. R38- Irritating to skin. R51/53- Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
Precautionary statements
S23- Do not breathe vapour or mist. S28- After contact with skin, wash immediately with plenty of soap and water. S36/37/39- Wear suitable protective clothing, gloves and eye/face protection. S51- Use only in well-ventilated areas. S61- Avoid release to the environment. Refer to special instructions/safety data sheet.
Hazardous Ingredients
Distillates (petroleum), hydrotreated middle
Supplemental label elements
Not applicable. elements
Special packaging requirements
Containers to be fitted Not applicable. with child-resistant fastenings
Tactile warning of danger
Not applicable.
Other hazards which do not result in classification
Defatting to the skin. Note: High Pressure Applications Injections through the skin resulting from contact with the product at high pressure constitute a major medical emergency. See 'Notes to physician' under First-Aid Measures, Section 4 of this Safety Data Sheet.
